Overview

MESA Treatment for NK/T Cell Lymphoma

Status:
Unknown status
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Study on the efficacy and safety of MESA chemotherapy for treating NK/T cell lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
Air Force Military Medical University, China
Fourth Military Medical University
Treatments:
Asparaginase
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Etoposide
Methotrexate